Efficacy and safety of vonoprazan-amoxicillin dual therapy for Helicobacter pylori first-line treatment: a single-center, randomized, controlled trial.
Therapeutic advances in gastroenterology（2023）
摘要
This study was registered at the Chinese Clinical Trial Registry (ChiCTR2100052550) on 30 October 2021.
更多查看译文
关键词
bismuth quadruple therapy, clarithromycin resistance, eradication treatment, Helicobacter pylori, vonoprazan-amoxicillin dual therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要